Midodrine (brand names Amatine, ProAmatine, Gutron) is a vasopressor/antihypotensive agent. Midodrine was approved in the United States by the Food and Drug Administration (FDA) in 1996 for the treatment of orthostatic hypotension. In August 2010, the FDA proposed withdrawing this approval because the manufacturer, Shire plc, has failed to complete required studies after the medicine reached the market. - Source: Wikipedia
- News
- Policy
-
Commentary
- Commentary Main
- Corrections
- Editorials
- Letters
- Cheryl K. Chumley
- Kelly Sadler
- Jed Babbin
- Tom Basile
- Tim Constantine
- Joseph Curl
- Joseph R. DeTrani
- Don Feder
- Billy Hallowell
- Daniel N. Hoffman
- David Keene
- Robert Knight
- Gene Marks
- Clifford D. May
- Michael McKenna
- Stephen Moore
- Tim Murtaugh
- Peter Navarro
- Everett Piper
- Cal Thomas
- Scott Walker
- Miles Yu
- Black Voices
- Books
- Cartoons
- To the Republic
- Sports
- Sponsored
- Events
-
Video/Podcasts
- Corrections
- All Videos
- All Podcasts
- The Front Page
- Threat Status
- Politically Unstable
- The Sitdown with Alex Swoyer
- Bold & Blunt
- The Higher Ground
- Court Watch
- Victory Over Communism
- District of Sports
- Capitol Hill Show
- The Unregulated Podcast
- ForAmerica
- Washington Times Weekly
- God, Country & American Story
- Games
-
- Subscribe
- Sign In